Global Apheresis Equipment Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Apheresis Equipment Market size is expected to reach USD 8.30 Billion in 2034 from USD 3.62 Billion (2025) growing at a CAGR of 9.66% during 2026-2034.

The Global Apheresis Equipment Market is growing significantly due to increasing demand for blood component separation in medical treatments. Apheresis procedures are commonly used for plasma collection, platelet donation, and therapeutic treatments for various autoimmune and hematological disorders. The rising prevalence of chronic diseases is boosting the need for advanced blood processing technologies.

Drivers include improvements in healthcare infrastructure, growing awareness about blood donation, and technological advancements in automated apheresis systems. Hospitals and blood banks are investing in efficient equipment to ensure safe and reliable procedures. Expanding research in cell therapy and regenerative medicine is also contributing to increased utilization of apheresis systems.

Future growth is expected as personalized medicine and advanced biologics gain momentum. The expansion of plasma-derived therapies and global demand for immunoglobulins may further drive equipment adoption. Continuous innovation focused on patient comfort, safety, and procedural efficiency will likely shape the long-term trajectory of this market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

Disposable Apheresis Kits
Devices

By Application

Renal Diseases
Hematology
Neurology
Others

By Procedure

Plasmapheresis
Photopheresis
Leukapheresis
Plateletpheresis
LDL Apheresis
Erythrocytapheresis
Others

By Technology

Membrane Filtration
Centrifugation

COMPANIES PROFILED

B Braun Melsungen AG, Haemonetics Corporation, Fresenius Kabi AG, Asahi Kasei Medical Co Ltd, Terumo BCT Inc, Mallinckrodt Plc, Nikkiso Europe GmbH, Cerus Corporation, Baxter International Inc, Kawasumi Laboratories Inc
We can customise the report as per your requirements.

Product Code: VMR112110300

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL APHERESIS EQUIPMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Product
4.2. Disposable Apheresis Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL APHERESIS EQUIPMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Application
5.2. Renal Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL APHERESIS EQUIPMENT MARKET: BY PROCEDURE 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Procedure
6.2. Plasmapheresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Photopheresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Leukapheresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Plateletpheresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.6. LDL Apheresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.7. Erythrocytapheresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL APHERESIS EQUIPMENT MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast Technology
7.2. Membrane Filtration Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Centrifugation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL APHERESIS EQUIPMENT MARKET: BY REGION 2022-2034(USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Product
- 8.2.2 By Application
- 8.2.3 By Procedure
- 8.2.4 By Technology
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Product
- 8.3.2 By Application
- 8.3.3 By Procedure
- 8.3.4 By Technology
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Product
- 8.4.2 By Application
- 8.4.3 By Procedure
- 8.4.4 By Technology
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Product
- 8.5.2 By Application
- 8.5.3 By Procedure
- 8.5.4 By Technology
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Product
- 8.6.2 By Application
- 8.6.3 By Procedure
- 8.6.4 By Technology
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL APHERESIS EQUIPMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 B. Braun Melsungen AG
- 10.2.2 Haemonetics Corporation
- 10.2.3 Fresenius Kabi AG
- 10.2.4 Asahi Kasei Medical Co. Ltd
- 10.2.5 Terumo BCT Inc
- 10.2.6 Mallinckrodt Plc
- 10.2.7 Nikkiso Europe GmbH
- 10.2.8 Cerus Corporation
- 10.2.9 Baxter International Inc
- 10.2.10 Kawasumi Laboratories Inc